Aptevo Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| GSA CAPITAL PARTNERS LLP | 08/06/2026 | 21.54 K | $96.00 K | 9.68% | 1.80% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 12.71 K | $56.45 K | 0.00% | 1.06% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 10.82 K | $48.04 K | -18.86% | 0.90% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 4.14 K | $18.39 K | 0.00% | 0.35% |
| UBS GROUP AG | 08/13/2026 | 730 | $3.24 K | -78.81% | 0.06% |
| ADVISOR GROUP HOLDINGS, INC. | 08/14/2026 | 360 | $1.60 K | 0.00% | 0.03% |
| SBI SECURITIES CO., LTD. | 07/23/2026 | 109 | $484 | 0.00% | 0.01% |
| BARCLAYS PLC | 08/14/2026 | 31 | $138 | 100.00% | 0.00% |
| DANSKE BANK A/S | 08/10/2026 | 1 | $4 | 0.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Aptevo Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 14 institutional investors and hedge funds held shares of Aptevo Therapeutics Inc. The most heavily invested institutionals were:
GSA CAPITAL PARTNERS LLP: 21,539
VANGUARD CAPITAL MANAGEMENT LLC: 12,713
GEODE CAPITAL MANAGEMENT, LLC: 10,821
VANGUARD FIDUCIARY TRUST CO: 4,142
UBS Group AG: 730
ADVISOR GROUP HOLDINGS, INC.: 360
4.22% of Aptevo Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 83.85 K shares in the last 24 months. This purchase volume represents approximately $553.38 K in transactions.